EP Lab

This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.

News | Antiplatelet and Anticoagulation Therapies

August 16, 2016 — Warfarin prescribed to prevent strokes in atrial fibrillation may not adequately control blood ...

Home August 16, 2016
Home
Sponsored Content | Videos | Inventory Management

Pacemakers, stents and bandages — keeping tracking of what is on hand and accurately capturing charges can be a ...

Home August 15, 2016
Home
Technology

August 15, 2016 — The U.S. Food and Drug Administration has granted market approval for the Biosense Webster Thermocool ...

Home August 15, 2016
Home
News | EP Lab

August 12, 2016 — Electrophysiology ablation navigation system company Stereotaxis Inc. announced its shares of common ...

Home August 12, 2016
Home
Technology | Implantable Cardioverter Defibrillator (ICD)

August 9, 2016 — The U.S. Food and Drug Administration (FDA) granted market approval for the Emblem MRI Subcutaneous ...

Home August 09, 2016
Home
Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC
Feature | Dave Fornell

 


August 5, 2016 — Here are the top 20 most popular current content on the Diagnostic and Interventional Cardiology ...

Home August 05, 2016
Home
Watchman, left atrial appendage closure, LAA occluder
Feature | Left Atrial Appendage (LAA) Occluders | Dave Fornell

Patients with atrial fibrillation (AF or Afib) are high risk for stroke due to the formation of thrombus emboli in the ...

Home August 01, 2016
Home
News | Blood Testing

July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc. will be ...

Home July 12, 2016
Home
pros and cons of new anticoagulation therapies, anticoagulants, dabigatran, Pradaxa, novel oral anticoagulants, NOACs, rivaroxaban, Xarelto, apixaban, Eliquis
Feature | Antiplatelet and Anticoagulation Therapies | Heidi Olson, Pharm.D

With the recent introduction of several novel oral anticoagulants (NOACs) on the U.S. market that have been billed by ...

Home July 26, 2016
Home
News | EP Mapping and Imaging Systems

July 7, 2016 — Abbott recently announced positive results from three clinical studies investigating the benefits ...

Home July 07, 2016
Home
News | Left Atrial Appendage (LAA) Occluders

July 7, 2016 — AtriCure Inc. announced the first patient has been enrolled in the FROST study at William Beaumont ...

Home July 07, 2016
Home
News | Left Atrial Appendage (LAA) Occluders

July 5, 2016 — AtriCure Inc. announced that it has received CE Mark for the AtriClip PRO2 Left Atrial Appendage (LAA) ...

Home July 05, 2016
Home
News | Heart Failure

July 5, 2016 — A research team has developed a new electric mesh device that can be wrapped around the heart to deliver ...

Home July 05, 2016
Home
News | Cardiac Diagnostics

July 1, 2016 — Research has already shown that taking anabolic steroids is associated with high blood pressure and an in ...

Home July 01, 2016
Home
Technology | Cardiac Resynchronization Therapy Devices (CRT)

June 28, 2016 — St. Jude Medical Inc. announced CE Mark approval and launch of SyncAV CRT software, designed to build ...

Home June 28, 2016
Home
Subscribe Now